RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY

There were presented results of clinical trials on β-adrenoblockers usage in patients with chronic heart failure (CHF) as well as data of own study on nebivolol efficacy and tolerability in 113 patients with ischemic heart disease, complicated with CHF. It is emphasized that therapy with β-adrenoblo...

Full description

Saved in:
Bibliographic Details
Main Author: M. L. Maximov
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/387
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227945249341440
author M. L. Maximov
author_facet M. L. Maximov
author_sort M. L. Maximov
collection DOAJ
description There were presented results of clinical trials on β-adrenoblockers usage in patients with chronic heart failure (CHF) as well as data of own study on nebivolol efficacy and tolerability in 113 patients with ischemic heart disease, complicated with CHF. It is emphasized that therapy with β-adrenoblockers positively influences on cardiac hemodynamics and CHF symptoms, significantly reduces mortality risk and the frequency of hospitalizations. The usage of β-adrenoblockers is indicated in CHF of any stage. Efficacy of metoprolol, bisoprolol and carvedilol had been proven in CHF therapy. Nebivolol was effective in elderly patients with CHF.
format Article
id doaj-art-80f463fc914749f3b8d6d04f1f1a9a93
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-80f463fc914749f3b8d6d04f1f1a9a932025-08-23T10:00:18ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0131606810.20996/1819-6446-2007-3-1-60-68387RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPYM. L. Maximov0Moscow medical academy named after I.M. SetchenovThere were presented results of clinical trials on β-adrenoblockers usage in patients with chronic heart failure (CHF) as well as data of own study on nebivolol efficacy and tolerability in 113 patients with ischemic heart disease, complicated with CHF. It is emphasized that therapy with β-adrenoblockers positively influences on cardiac hemodynamics and CHF symptoms, significantly reduces mortality risk and the frequency of hospitalizations. The usage of β-adrenoblockers is indicated in CHF of any stage. Efficacy of metoprolol, bisoprolol and carvedilol had been proven in CHF therapy. Nebivolol was effective in elderly patients with CHF.https://www.rpcardio.online/jour/article/view/387chronic heart failureβ-adrenoblockersnebivolol
spellingShingle M. L. Maximov
RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
Рациональная фармакотерапия в кардиологии
chronic heart failure
β-adrenoblockers
nebivolol
title RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
title_full RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
title_fullStr RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
title_full_unstemmed RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
title_short RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
title_sort rational choice of β adrenoblockers in chronic heart failure therapy
topic chronic heart failure
β-adrenoblockers
nebivolol
url https://www.rpcardio.online/jour/article/view/387
work_keys_str_mv AT mlmaximov rationalchoiceofbadrenoblockersinchronicheartfailuretherapy